Gemcitabine plus Platinum in Recurrent Platinum Sensitive Epithelial Ovarian Cancer
Alaa Abdel-Hameed Sharshar;
Abstract
O
varian cancer remains the leading cause of gynecologic cancer death. World wide, there are 166000 cases and 101000 deaths from ovarian cancer each year. Overall, ovarian cancer accounts for 5% of all cancer deaths, and 4% of all cancer diagnosis in wom
varian cancer remains the leading cause of gynecologic cancer death. World wide, there are 166000 cases and 101000 deaths from ovarian cancer each year. Overall, ovarian cancer accounts for 5% of all cancer deaths, and 4% of all cancer diagnosis in wom
Other data
| Title | Gemcitabine plus Platinum in Recurrent Platinum Sensitive Epithelial Ovarian Cancer | Other Titles | استخدام عقاري الجيمسيتابين والبلاتينوم في علاج سرطان المبيض الظهاري المرتجع المستجيب للبلاتينوم | Authors | Alaa Abdel-Hameed Sharshar | Keywords | Gemcitabine plus Platinum in Recurrent Platinum Sensitive Epithelial Ovarian Cancer | Issue Date | 2009 | Description | O varian cancer remains the leading cause of gynecologic cancer death. World wide, there are 166000 cases and 101000 deaths from ovarian cancer each year. Overall, ovarian cancer accounts for 5% of all cancer deaths, and 4% of all cancer diagnosis in wom |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 91205Dr.Alaa Final.pdf | 234.62 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.